| 136 |
Intracellular Acidification Induced Olfactory Epithelial Injury Leading to Site of Contact Nasal Tumors |
Undefined |
BY-SA |
867: Decrease, Intracellular pH
|
872: Increase, Site of Contact Nasal Tumors
|
Under Review |
2.7 |
| 11 |
Percellome Toxicogenomics Approach for AOP Building: Case study on Pentachlorophenol |
Jun Kanno |
BY-SA |
245: Activation, PXR/SXR
|
None
|
Under Development |
2.5 |
| 6 |
Antagonist binding to PPARα leading to body-weight loss |
Kurt A. Gust |
BY-SA |
998: Binding of antagonist, PPAR alpha
|
864: Decreased, Body Weight
|
WPHA/WNT Endorsed |
2.3 |
| 437 |
Inhibition of mitochondrial electron transport chain (ETC) complexes leading to kidney toxicity |
Baki Sadi |
BY-SA |
105: Inhibition, Mitochondrial Electron Transport Chain Complexes
|
814: Occurrence, Kidney toxicity
|
Under Development |
1.99 |
| 524 |
Gluten-driven immune activation leading to celiac disease in genetically predisposed individuals |
Antonio Fernandez Dumont |
BY-SA |
3 MIEs
|
2257: Celiac disease
|
Under Review |
1.98 |
| 398 |
Decreased ALDH1A (RALDH) activity leading to decreased fertility via disrupted meiotic initiation of fetal oogonia |
Terje Svingen |
BY-SA |
1880: Decreased, ALDH1A (RALDH) enzyme activity
|
406: decreased, Fertility
|
Under Development |
1.97 |
| 412 |
Endothelial cell dysfunction leading to thromboinflammation |
Luigi Margiotta-Casaluci |
BY-SA |
None
|
1916: Thromboinflammation, Increased
|
Under Development |
1.96 |
| 422 |
Binding of SARS-CoV-2 to ACE2 in enterocytes leads to intestinal barrier disruption |
Laure-Alix Clerbaux |
BY-SA |
1739: Binding to ACE2
|
None
|
Under Development |
1.96 |
| 428 |
Binding of S-protein to ACE2 in enterocytes induces ACE2 dysregulation leading to gut dysbiosis |
Laure-Alix Clerbaux |
BY-SA |
1739: Binding to ACE2
|
None
|
Under Development |
1.96 |
| 430 |
Binding of SARS-CoV-2 to ACE2 leads to viral infection proliferation |
Sally Mayasich |
BY-SA |
1739: Binding to ACE2
|
1939: Viral infection and host-to-host transmission, proliferated
|
Under Development |
1.96 |
| 374 |
Binding of Sars-CoV-2 spike protein to ACE 2 receptors expressed on brain cells (neuronal and non-neuronal) leads to neuroinflammation resulting in encephalitis |
Anna Price |
BY-SA |
1739: Binding to ACE2
|
1841: Encephalitis
|
Under Development |
1.96 |
| 379 |
Binding to ACE2 leading to thrombosis and disseminated intravascular coagulation |
Shihori Tanabe |
All rights reserved |
1739: Binding to ACE2
|
1846: Thrombosis and Disseminated Intravascular Coagulation
|
Under Development |
1.96 |
| 381 |
Binding of viral S-glycoprotein to ACE2 receptor leading to dysgeusia |
Young Jun Kim |
BY-SA |
1739: Binding to ACE2
|
1850: dysgeusia
|
Under Development |
1.96 |
| 382 |
Angiotensin II type 1 receptor (AT1R) agonism leading to lung fibrosis |
Young Jun Kim |
BY-SA |
1851: Binding of agonist, Angiotensin II receptor type 1 receptor (AT1R)
|
1276: Lung fibrosis
|
Under Development |
1.96 |
| 383 |
Inhibition of Angiotensin-converting enzyme 2 leading to liver fibrosis |
Young Jun Kim |
BY-SA |
1740: Induced dysregulation of ACE2
|
344: Increase, Liver fibrosis
|
Under Development |
1.96 |
| 392 |
Decreased fibrinolysis and activated bradykinin system leading to hyperinflammation |
Penny Nymark |
BY-SA |
2 MIEs
|
1868: Hyperinflammation
|
Under Development |
1.96 |
| 394 |
SARS-CoV-2 infection of olfactory epithelium leading to impaired olfactory function (short-term anosmia) |
Sandra Coecke |
BY-SA |
1739: Binding to ACE2
|
1873: impaired olfactory function (anosmia)
|
Under Development |
1.96 |
| 395 |
Binding of Sars-CoV-2 spike protein to ACE 2 receptors expressed on pericytes leads to disseminated intravascular coagulation resulting in cerebrovascular disease (stroke) |
Magda Sachana |
BY-SA |
1739: Binding to ACE2
|
1875: Cerebrovascular disease (stroke)
|
Under Development |
1.96 |
| 319 |
Binding to ACE2 leading to lung fibrosis |
Young Jun Kim |
BY-SA |
1740: Induced dysregulation of ACE2
|
1276: Lung fibrosis
|
Under Development |
1.96 |
| 320 |
Binding of SARS-CoV-2 to ACE2 receptor leading to acute respiratory distress associated mortality |
Young Jun Kim |
BY-SA |
1739: Binding to ACE2
|
351: Increased Mortality
|
Under Development |
1.96 |
| 358 |
Chitinase inhibition leading to mortality |
Simon Schmid |
BY-SA |
1806: Inhibition, Chitinase
|
350: Increase, Mortality
|
Under Development |
1.94 |
| 359 |
Chitobiase inhibition leading to mortality |
Simon Schmid |
BY-SA |
1807: Inhibition, Chitobiase
|
350: Increase, Mortality
|
Under Development |
1.94 |
| 360 |
Chitin synthase 1 inhibition leading to mortality |
Simon Schmid |
BY-SA |
1522: Inhibition, Chitin synthase 1
|
350: Increase, Mortality
|
WPHA/WNT Endorsed |
1.94 |
| 361 |
Sulfonylureareceptor binding leading to mortality |
Simon Schmid |
BY-SA |
1525: Increase, Sulfonylurea receptor binding
|
350: Increase, Mortality
|
Under Development |
1.94 |
| 348 |
Inhibition of 11β-Hydroxysteroid Dehydrogenase leading to decreased population trajectory |
Young Jun Kim |
BY-SA |
1799: Inhibition of 11β-HSD
|
360: Decrease, Population growth rate
|
Under Development |
1.93 |